Skip to main content
logo
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
2,030.70
+12.10 (0.60%)
Sep 25, 2025, 3:30 PM IST

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 32.64B INR in the quarter ending June 30, 2025, with 0.62% growth. This brings the company's revenue in the last twelve months to 134.56B, up 4.62% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.

Revenue (ttm)
134.56B
Revenue Growth
+4.62%
P/S Ratio
4.26
Revenue / Employee
8.52M
Employees
15,800
Market Cap
573.07B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025133.63B7.18B5.68%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Apollo Hospitals Enterprise225.51B
Mankind Pharma129.10B
Zydus Lifesciences236.08B
Fortis Healthcare80.94B
Alkem Laboratories133.04B
Revenue Rankings

Glenmark Pharmaceuticals News

More News